ClinicalTrials.Veeva

Menu

Effect of Organic Naked Oat With Whole Germ on Type 2 Diabetes Mellitus

Y

Yong Li

Status

Completed

Conditions

Diabetes Mellitus

Treatments

Dietary Supplement: organic naked oat with whole germ (ONOG)

Study type

Interventional

Funder types

Other

Identifiers

NCT01495052
ONOG-0001
ONOG-0001-01 (Other Identifier)

Details and patient eligibility

About

Dietary modification is of great essential for the prevention and treatment of type 2 diabetes mellitus. Common oat (Avena sativa L.) and its products showed a great potential benefits on NCDs including type 2 diabetes mellitus. But data about such effects of naked oat (Avena nuda L.) is still unavailable. The investigators aimed to examine the effects of organic naked oat with whole germ (ONOG) plus diet on patients with type 2 diabetes.

After a pre-study with healthy adults, a randomized, single-blinded, multi-arm parallel trial of 30 days would be carried out in adults of 50-65 years old with type 2 diabetes. Participants would be randomly assigned to one of the four following groups: usual care group (only basic health advice, no other interventions), diet group (systematic education, structured dietary), 50g-ONOG plus diet group (all the interventions of diet group plus replacement of 50g ONOG per day) and 100g-ONOG plus diet group. A regular follow-up for years would be carried out to predict the long-term effects of ONOG plus diet intervention on patients with type 2 diabetes.

The investigators hypothesized that ONOG combined with diet would have better effects on glycaemia and insulin resistance control in addition to those yielded by diet or usual care.

Enrollment

445 patients

Sex

All

Ages

50 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • all adults aged 50-65 years old with Type 2 Diabetes Mellitus
  • stable physical condition
  • fasting plasma glucose (FPG) concentration ≥7.8mmol/L or 2-h postprandial blood glucose (PG) ≥11.1mmol/L after 75g oral dextrose with an glycated hemoglobin (HbA1c)>7 %, stable medication.

Exclusion criteria

  • pregnancy
  • breastfeeding
  • severe renal or hepatic complications
  • treatment by glucocorticoid
  • having pancreatic disease or malignancy in recent 3 months
  • other factors that may limit adherence to interventions or affect conduct of the trial or participation in another supplementary feeding programme.

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

445 participants in 4 patient groups

Usual care group
No Intervention group
Description:
The usual care group was used as control group and didn't receive any intervention except standard health advice at the beginning and the end of the study.
diet group
No Intervention group
Description:
This group received systematic education about nutrition and diabetes combined with a structured dietary intervention.
50g-ONOG plus diet group
Experimental group
Description:
This group received systematic education about nutrition and diabetes combined with a structured dietary intervention. Participants in the 50g-ONOG plus diet groups were asked to replace their customarily used staple food with oat porridge containing 50g ONOG.
Treatment:
Dietary Supplement: organic naked oat with whole germ (ONOG)
100g-ONOG plus diet group
Experimental group
Description:
This group received systematic education about nutrition and diabetes combined with a structured dietary intervention. Participants in the 100g-ONOG plus diet groups were asked to replace their customarily used staple food with oat porridge containing 100g ONOG.
Treatment:
Dietary Supplement: organic naked oat with whole germ (ONOG)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems